Takeda's Nycomed buyout wins E.U. nod; Novo to relocate North American HQ;

@FiercePharma: Add another state AG to the list of Risperdal plaintiffs. Now it's Mass. claiming J&J's marketing crossed the line. News | Follow @FiercePharma

> Takeda's $13.68 billion acquisition of the Swiss drugmaker Nycomed won regulatory approval in the E.U. News

> Novo Nordisk plans to move its North American headquarters to Plainsboro, NJ, from Princeton, bringing 1,200 jobs along with it. Item

> The FDA found counterfeit versions of the morning-after birth control pill Evital imported for sale in the U.S., where the drug is not approved. Article

> Pfizer wrapped up the sale of its Capsugel unit to the investment firm KKR for $2.3 billion in cash. Pfizer release

> GlaxoSmithKline's new epilepsy drug Trobalt got a thumbs up from the U.K.'s cost-effectiveness watchdog for use as an add-on therapy. Story

> Ranbaxy Laboratories and parent company Daiichi Sankyo will expand their Mexican footprint with the launch of a generic version of the blood pressure drug Benicar. Item

> Hungary's Geodon Richter saw second-quarter profit drop by 68% on higher sales and marketing costs associated with its development of a sales network in former Soviet bloc countries. Report 

Biotech News

@FierceBiotech: Teva's oral MS drug trips (again) in blockbuster Ph3 development race. News | Follow @FierceBiotech

@JohnCFierce: Arena makes case that lorcaserin shouldn't significantly increase risk of brain tumors. But can they convince FDA? Article | Follow @JohnCFierce

@RyanMFierce: Sequencing giant BGI shoots for the cloud, look out Complete Genomics? Item | Follow @RyanMFierce

@MaureenFierce: Actelion's experimental multiple sclerosis drug ponesimod met main goal in Phase II trial. Piece | Follow @MaureenFierce

> Insmed shares crater as FDA puts a clamp of Ph3 CF study. Story

> Can Arena's latest safety study help satisfy FDA cancer worries? Report

Biotech Research News

> U.S. gives out $5M for antiradiation drugs in case of attack. Item

> Leukemia drug helps reverse tamoxifen resistance in breast cancer. News

> A transcriptional time machine may turn back the clock on leukemia. Article

> Genes help personalized stomach cancer treatments. Report

> Of mice, men, sex, and violence. Story

> Nicotine eyed as Parkinson's treatment. More

Manufacturing News

> How an ops driving lesson may have saved former Pfizer CEO Kindler. More

> Shippers organize air cargo to win over pharma. Story

> UN: Pharma CMOs fare well in investment by developing countries. Article

> Compounding pharmacies shine during drug shortages. Report

And Finally... GlaxoSmithKline has been using reverse auctions to drive down legal fees, spooking law firms. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.